Approval · Notice of Compliance 7373 · 2005
ATARAX: Notice of Compliance 7373
Issued September 14, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7373
- Date
- September 14, 2005
- Company
- Erfa Canada Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Anxiolytic, antihistamine agent
Products in this notice
Medicinal ingredients
- HYDROXYZINE HCL 10 MG per CAP
- HYDROXYZINE HCL 25 MG per CAP
- HYDROXYZINE HCL 50 MG per CAP